MLchartDataset catalogue

acitretin

Term · Oncology and biomedicine · MLC-T-ONC-000158

  1. A substance that is used in the prevention of cancer and in the treatment of psoriasis. It belongs to the family of drugs called retinoids.

  2. An orally-active metabolite of the synthetic aromatic retinoic acid agent etretinate with potential antineoplastic, chemopreventive, anti-psoratic, and embryotoxic properties. Acitretin activates nuclear retinoic acid receptors (RAR), resulting in induction of cell differentiation, inhibition of cell proliferation, and inhibition of tissue infiltration by inflammatory cells. This agent may also inhibit tumor angiogenesis.

Table 1. Record
IdentifierMLC-T-ONC-000158
FieldOncology and biomedicine
SynonymsTrimethylmethoxyphenyl-retinoic acid
ReferencesNCI Dictionary of Cancer Terms; National Cancer Institute Thesaurus (CC BY 4.0)
Record as JSON
{
  "id": "MLC-T-ONC-000158",
  "term": "acitretin",
  "field": "Oncology and biomedicine",
  "definitions": [
    "A substance that is used in the prevention of cancer and in the treatment of psoriasis. It belongs to the family of drugs called retinoids.",
    "An orally-active metabolite of the synthetic aromatic retinoic acid agent etretinate with potential antineoplastic, chemopreventive, anti-psoratic, and embryotoxic properties. Acitretin activates nuclear retinoic acid receptors (RAR), resulting in induction of cell differentiation, inhibition of cell proliferation, and inhibition of tissue infiltration by inflammatory cells. This agent may also inhibit tumor angiogenesis."
  ],
  "synonyms": [
    "Trimethylmethoxyphenyl-retinoic acid"
  ],
  "references": [
    "NCI Dictionary of Cancer Terms",
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/acitretin/"
}

Record 255 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.